PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Critical Care, Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, United Kingdom.\', \'Department of Respiratory Medicine, Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, United Kingdom.\', \'Department of Diabetes, Endocrinology and Metabolism, Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, United Kingdom.\', \'Lung Function & Sleep, Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, United Kingdom.\', \'Department of Infectious Disease, Heart of England Hospital, University Hospitals Birmingham, Birmingham, United Kingdom.\', \'Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciab341
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33893486
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Medium-Term Outcomes in Severely to Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all